Stryker (SYK) Cash from Operations (2009 - 2026)
Stryker's (SYK) quarterly Cash from Operations came in at $1.3 billion in Q2 2026, up 13.5% year-over-year from $1.1 billion in Q2 2025, and up 117.04% quarter-over-quarter from $581.0 million in Q1 2026.
Analysis
Stryker (SYK) Cash from Operations (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Cash from Operations for 18 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 13.5% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $5.5 billion, a 15.93% increase from a year earlier, with the FY2025 full-year figure at $5.0 billion, up 18.91% from the prior year.
- Cash from Operations was $1.3 billion for Q2 2026 at Stryker, up from $581.0 million in the prior quarter.
- Over five years, Cash from Operations peaked at $2.1 billion in Q4 2025 and troughed at $203.0 million in Q1 2022.
- A 5-year average of $970.2 million and a median of $946.0 million in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 55.09% in 2022 and soared 132.4% in 2026, its largest moves.
- Over 5 years, Cash from Operations stood at $1.0 billion in 2022, then jumped by 52.34% to $1.5 billion in 2023, then increased by 26.37% to $1.9 billion in 2024, then advanced by 10.98% to $2.1 billion in 2025, then plunged by 41.16% to $1.3 billion in 2026.
- The last three Cash from Operations figures came in at $1.3 billion (Q2 2026), $581.0 million (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 447.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Mar 31, 2026 | 581.00 Mn |
| Dec 31, 2025 | 2.14 Bn |
| Sep 30, 2025 | 1.54 Bn |
| Jun 30, 2025 | 1.11 Bn |
| Mar 31, 2025 | 250.00 Mn |
| Dec 31, 2024 | 1.93 Bn |
| Sep 30, 2024 | 1.47 Bn |
| Jun 30, 2024 | 633.00 Mn |
| Mar 31, 2024 | 204.00 Mn |
| Dec 31, 2023 | 1.53 Bn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 688.00 Mn |
| Mar 31, 2023 | 445.00 Mn |
| Dec 31, 2022 | 1.00 Bn |
| Sep 30, 2022 | 889.00 Mn |
| Jun 30, 2022 | 529.00 Mn |
| Mar 31, 2022 | 203.00 Mn |
| Dec 31, 2021 | 1.00 Bn |
| Sep 30, 2021 | 933.00 Mn |